Your payment is in progress...
  +1 (704) 266-3234

Thyroid Cancer Drugs Global Market Report 2020 Including: 1) By Drug Type: Ipilimumab, Cabozantinib-S-Malate, Caprelsa (Vandetanib), Doxorubicin Hydrochloride, Lenvatinib Mesylate, Nivolumab, Vandetanib, Others 2) By End Users: Hospitals, Oncology Clinics, Research Organizations, Others 3) By Type: Radioiodine Ablation, Thyroid Stimulating Hormone (THS) Suppression, Chemotherapy, Targeted Multikinase Therapy, Others Covering: Mylan Pharmaceuticals Inc., Alara Pharmaceutical Corporation, Bristol Myers Co., Teva Parenteral Medicines Inc., Jerome Stevens Pharmaceuticals Inc.

Published on: Dec 2019 | From USD $4000 | Published By: THE BUSINESS RESEARCH COMPANY | Number Of Pages: 200

The thyroid cancer drugs market consists of sales of drugs that are used to treat thyroid cancer. The thyroid tissue is made up of follicular cells and parafollicular cells in which cancer develops. The types of thyroid cancer include follicular, papillary, medullary, anaplastic and thyroid lymphoma.

The global thyroid cancer drugs market was valued at about $0.4 billion in 2018 and is expected to grow to $0.77 billion at a CAGR of 17.7% through 2022.

North America was the largest region in the thyroid cancer drugs market in 2018, followed by Europe. The thyroid cancer drugs market in Asia Pacific is forecasted to register the highest CAGR during 2018-2023.

Increasing incidences of thyroid cancer, especially in women is driving the thyroid cancer drugs market. According to the American Cancer Society, women are three times more likely to develop thyroid cancer than men. Thyroid cancer is rising at a fast pace and it is estimated that 52,070 new cases of thyroid cancer will be found in the USA in 2019 and an estimated 2,170 deaths will occur because of the disease. The increase in thyroid cancer can be attributed to exposure to radiation, family history of goiter and some hereditary syndromes. 

Increasing use of targeted therapies for the treatment of thyroid cancer is acting as a restraint on the thyroid cancer drugs market. Targeted therapies target cancer specific genes, proteins and tissues that promote cancer growth and survival. Targeted therapies are increasingly being used to treat thyroid cancer as thyroid hormone-based treatments including radioactive iodine therapy are not effective against these cancers. For example, Vandetanib (Caprelsa) and Cabozantinib (Cometriq) are targeted therapies used to treat advanced medullary thyroid cancer (MTC). As patients increasingly use targeted therapies for treatment, demand for thyroid cancer drugs is decreasing, affecting market growth.

Combination drugs are increasingly being used in the treatment of thyroid cancer as they are more effective and help prevent cancer progression. A combination drug includes two or more active pharmaceutical ingredients (APIs) combined in a single dosage form. These drugs reduce the development of drug resistance and prevent the growth of cancer cells. For instance, in 2018, the FDA approved the combination of dabrafenib (Tafinlar), a BRAF inhibitor, and trametinib (Mekinist), a MEK inhibitor for the treatment of anaplastic thyroid cancer.

Manufacturers of thyroid cancer drugs are governed by regulatory authorities such as the Food and Drug Administration in the USA. For instance, off-label usage of FDA approved drugs for the treatment of cancer requires approval from the FDA. Manufacturers are required to submit a supplemental marketing application called sNDA( Supplemental New Drug Application) to the FDA that approves the drug for prescription.

In February 2019, Eli Lilly and Company acquired Loxo Oncology, Inc.for $8 Billion. The acquisition provides Eli Lilly access to a pipeline of investigational medicines like RET inhibitors which are used in thyroid cancer treatment. Loxo Oncology was established in 2013 and is located in Stamford, USA.

Major players in the market are Mylan Pharmaceuticals Inc., Alara Pharmaceutical Corporation, Bristol Myers co., Teva parenteral medicines Inc., Jerome Stevens Pharmaceuticals Inc.

Thyroid Cancer Drugs Market Global Report 2020 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the global thyroid cancer drugs market.

Reasons to Purchase
• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market research findings.
• Benchmark performance against key competitors.
• Utilize the relationships between key data sets for superior strategizing.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Description:
Where is the largest and fastest growing market for the thyroid cancer drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Thyroid Cancer Drugs Market Global Report from The Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market.
• The Market Characteristics section of the report defines and explains the market.
• The Market Size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
• Market Segmentations break down market into sub markets.
• The Regional and Country section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
• Competitive Landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The Trends and Strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.

Scope

Markets Covered: 1) By Drug Type: Ipilimumab, Cabozantinib-S-Malate, Caprelsa (Vandetanib), Doxorubicin Hydrochloride, Lenvatinib Mesylate, Nivolumab, Vandetanib, Others 2) By End Users: Hospitals, Oncology Clinics, Research Organizations, Others 3) By Type: Radioiodine Ablation, Thyroid Stimulating Hormone (THS) Suppression, Chemotherapy, Targeted Multikinase Therapy, Others

Companies Mentioned: Mylan Pharmaceuticals Inc., Alara Pharmaceutical Corporation, Bristol Myers co., Teva parenteral medicines Inc., Jerome Stevens Pharmaceuticals Inc.

Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Time Series: Five years historic and forecast.

Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

1. Executive Summary
2. Thyroid Cancer Drugs Market Characteristics
3. Thyroid Cancer Drugs Market Size And Growth
3.1. Global Thyroid Cancer Drugs Historic Market, 2015 - 2019, $ Billion
3.1.1. Drivers Of The Market
3.1.2. Restraints On The Market
3.2. Global Thyroid Cancer Drugs Forecast Market, 2019 - 2022F, 2025F, 2030F, $ Billion
3.2.1. Drivers Of The Market
3.2.2. Restraints On the Market
4. Thyroid Cancer Drugs Market Segmentation
4.1. Global Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Ipilimumab
Cabozantinib-S-Malate
Caprelsa (Vandetanib)
Doxorubicin Hydrochloride
Lenvatinib Mesylate
Nivolumab
Vandetanib
Others
4.2. Global Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Hospitals
Oncology Clinics
Research Organizations
Others
4.3. Global Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Radioiodine Ablation
Thyroid Stimulating Hormone (THS) Suppression
Chemotherapy
Targeted Multikinase Therapy
Others
5. Thyroid Cancer Drugs Market Regional And Country Analysis
5.1. Global Thyroid Cancer Drugs Market, Split By Region, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
5.2. Global Thyroid Cancer Drugs Market, Split By Country, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
6. Asia-Pacific Thyroid Cancer Drugs Market
6.1. Asia-Pacific Thyroid Cancer Drugs Market Overview
6.2. Asia-Pacific Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
6.3. Asia-Pacific Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
6.4. Asia-Pacific Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
7. China Thyroid Cancer Drugs Market
7.1. China Thyroid Cancer Drugs Market Overview
7.2. China Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F,$ Billion
7.3. China Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F,$ Billion
7.4. China Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F,$ Billion
8. India Thyroid Cancer Drugs Market
8.1. India Thyroid Cancer Drugs Market Overview
8.2. India Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
8.3. India Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
8.4. India Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
9. Japan Thyroid Cancer Drugs Market
9.1. Japan Thyroid Cancer Drugs Market Overview
9.2. Japan Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
9.3. Japan Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
9.4. Japan Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
10. Australia Thyroid Cancer Drugs Market
10.1. Australia Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
10.2. Australia Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
10.3. Australia Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
11. Indonesia Thyroid Cancer Drugs Market
11.1. Indonesia Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
11.2. Indonesia Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
11.3. Indonesia Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
12. South Korea Thyroid Cancer Drugs Market
12.1. South Korea Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
12.2. South Korea Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
12.3. South Korea Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
13. Western Europe Thyroid Cancer Drugs Market
13.1. Western Europe Thyroid Cancer Drugs Market Overview
13.2. Western Europe Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
13.3. Western Europe Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
13.4. Western Europe Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
14. UK Thyroid Cancer Drugs Market
14.1. UK Thyroid Cancer Drugs Market Overview
14.2. UK Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
14.3. UK Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
14.4. UK Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
15. Germany Thyroid Cancer Drugs Market
15.1. Germany Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
15.2. Germany Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
15.3. Germany Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
16. France Thyroid Cancer Drugs Market
16.5. France Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
16.6. France Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
16.7. France Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
17. Eastern Europe Thyroid Cancer Drugs Market
17.1. Eastern Europe Thyroid Cancer Drugs Market Overview
17.2. Eastern Europe Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
17.3. Eastern Europe Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
17.4. Eastern Europe Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
18. Russia Thyroid Cancer Drugs Market
18.1. Russia Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
18.2. Russia Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
18.3. Russia Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
19. North America Thyroid Cancer Drugs Market
19.1. North America Thyroid Cancer Drugs Market Overview
19.2. North America Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
19.3. North America Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
19.4. North America Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
20. USA Thyroid Cancer Drugs Market
20.1. USA Thyroid Cancer Drugs Market Overview
20.2. USA Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
20.3. USA Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
20.4. USA Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
21. South America Thyroid Cancer Drugs Market
21.1. South America Thyroid Cancer Drugs Market Overview
21.2. South America Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
21.3. South America Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
21.4. South America Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
22. Brazil Thyroid Cancer Drugs Market
22.1. Brazil Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
22.2. Brazil Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
22.3. Brazil Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
23. Middle East Thyroid Cancer Drugs Market
23.1. Middle East Thyroid Cancer Drugs Market Overview
23.2. Middle East Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
23.3. Middle East Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
23.4. Middle East Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
24. Africa Thyroid Cancer Drugs Market
24.1. Africa Thyroid Cancer Drugs Market Overview
24.2. Africa Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
24.3. Africa Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
24.4. Africa Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
25. Thyroid Cancer Drugs Market Competitive Landscape And Company Profiles
25.1. Thyroid Cancer Drugs Market Competitive Landscape
25.2. Thyroid Cancer Drugs Market Company Profiles
25.2.1. Mylan Pharmaceuticals Inc.
25.2.1.1. Overview
25.2.1.2. Products and Services
25.2.1.3. Strategy
25.2.1.4. Financial Performance
25.2.2. Alara Pharmaceutical Corporation
25.2.2.1. Overview
25.2.2.2. Products and Services
25.2.2.3. Strategy
25.2.2.4. Financial Performance
25.2.3. Bristol Myers co.
25.2.3.1. Overview
25.2.3.2. Products and Services
25.2.3.3. Strategy
25.2.3.4. Financial Performance
25.2.4. Teva parenteral medicines Inc.
25.2.4.1. Overview
25.2.4.2. Products and Services
25.2.4.3. Strategy
25.2.4.4. Financial Performance
25.2.5. Jerome Stevens Pharmaceuticals Inc.
25.2.5.1. Overview
25.2.5.2. Products and Services
25.2.5.3. Strategy
25.2.5.4. Financial Performance
26. Key Mergers And Acquisitions In The Thyroid Cancer Drugs Market
27. Thyroid Cancer Drugs Market Trends And Strategies
28. Product Pipeline Analysis
29. Thyroid Cancer Drugs Market Future Outlook and Potential Analysis
30. Appendix
30.1. Abbreviations
30.2. Currencies
30.3. Research Inquiries
30.4. The Business Research Company
30.5. Copyright And Disclaimer

Table 1: Global Historic Market Growth, 2015-2019, $ Billion
Table 2: Global Forecast Market Growth, 2015-2022F, 2025F, 2030F, $ Billion
Table 3: Global Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 4: Global Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 5: Global Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 6: Global Thyroid Cancer Drugs Market, Split By Region, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 7: Global Thyroid Cancer Drugs Market, Split By Country, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 8: Asia-Pacific, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 9: Asia-Pacific, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 10: Asia-Pacific, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 11: China, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 12: China, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 13: China, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 14: India, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 15: India, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 16: India, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 17: Japan, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 18: Japan, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 19: Japan, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 20: Australia, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 21: Australia, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 22: Australia, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 23: Indonesia, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 24: Indonesia, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 25: Indonesia, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 26: South Korea, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 27: South Korea, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 28: South Korea, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 29: Western Europe, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 30: Western Europe, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 31: Western Europe, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 32: UK, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 33: UK, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 34: UK, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 35: Germany, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 36: Germany, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 37: Germany, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 38: France, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 39: France, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 40: France, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 41: Eastern Europe, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 42: Eastern Europe, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 43: Eastern Europe, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 44: Russia, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 45: Russia, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 46: Russia, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 47: North America, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 48: North America, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 49: North America, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 50: USA, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 51: USA, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 52: USA, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 53: South America, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 54: South America, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 55: South America, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 56: Brazil, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 57: Brazil, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 58: Brazil, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 59: Middle East, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 60: Middle East, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 61: Middle East, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 62: Africa, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 63: Africa, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 64: Africa, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 65: Mylan Pharmaceuticals Inc. Financial Performance
Table 66: Alara Pharmaceutical Corporation Financial Performance
Table 67: Bristol Myers co. Financial Performance
Table 68: Teva parenteral medicines Inc. Financial Performance
Table 69: Jerome Stevens Pharmaceuticals Inc. Financial Performance


Figure 1: Global Historic Market Growth, 2015-2019, $ Billion
Figure 2: Global Forecast Market Growth, 2015-2022F, 2025F, 2030F, $ Billion
Figure 3: Global Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 4: Global Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 5: Global Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 6: Global Thyroid Cancer Drugs Market, Split By Region, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 7: Global Thyroid Cancer Drugs Market, Split By Country, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 8: Asia-Pacific, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 9: Asia-Pacific, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 10: Asia-Pacific, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 11: China, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 12: China, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 13: China, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 14: India, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 15: India, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 16: India, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 17: Japan, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 18: Japan, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 19: Japan, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 20: Australia, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 21: Australia, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 22: Australia, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 23: Indonesia, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 24: Indonesia, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 25: Indonesia, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 26: South Korea, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 27: South Korea, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 28: South Korea, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 29: Western Europe, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 30: Western Europe, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 31: Western Europe, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 32: UK, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 33: UK, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 34: UK, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 35: Germany, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 36: Germany, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 37: Germany, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 38: France, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 39: France, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 40: France, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 41: Eastern Europe, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 42: Eastern Europe, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 43: Eastern Europe, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 44: Russia, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 45: Russia, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 46: Russia, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 47: North America, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 48: North America, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 49: North America, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 50: USA, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 51: USA, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 52: USA, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 53: South America, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 54: South America, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 55: South America, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 56: Brazil, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 57: Brazil, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 58: Brazil, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 59: Middle East, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 60: Middle East, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 61: Middle East, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 62: Africa, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 63: Africa, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 64: Africa, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 65: Mylan Pharmaceuticals Inc. Financial Performance
Figure 66: Alara Pharmaceutical Corporation Financial Performance
Figure 67: Bristol Myers co. Financial Performance
Figure 68: Teva parenteral medicines Inc. Financial Performance
Figure 69: Jerome Stevens Pharmaceuticals Inc. Financial Performance

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Please Choose License Type

USD $4000
USD $6000
USD $8000
Offer

Why Us

  • Why Us In-depth database
    Our Report’s database covers almost all topics of all regions over the Globe..
  • Why Us Recognised publishing sources
    Tie ups with top publishers around the globe.
  • Why Us Customer Support
    Complete pre and post sales support.
  • Why Us Safe & Secure
    Complete secure payment process.